Intensity Therapeutics INTS
NASDAQ INTS
$3.28 -0.01 (-0.30%)
As of: Oct 20, 2026 · 3:59 PM EDT

Intensity Therapeutics (INTS) Common Stock Issued (2023 - 2026)

Updated

Analysis

Intensity Therapeutics (INTS) Common Stock Issued (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 359.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 6.00 Mn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 9.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Intensity Therapeutics 8.93 Mn -29.83 Mn - -157,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -157,000.00
Mar 31, 2026 157,000.00
Dec 31, 2025 56,000.00
Jun 30, 2025 4.31 Mn
Mar 31, 2025 345,000.00
Dec 31, 2024 47,000.00
Sep 30, 2024 263,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 8,000.00
Sep 30, 2023 22.48 Mn
API Access

Intensity Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=INTS&period=max&api_key=YOUR_API_KEY